Benzathine Penicillin Intramuscular Injection Suppliers & Bulk Manufacturers
Available Forms: Intramuscular Injection
Available Strengths: 600,000 units / mL; 1.2 million units / mL
Reference Brands: Bicillin L-A, Bicillin C-R(US)
Category:
Antibiotics
Benzathine Penicillin IM inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial cell lysis and death. It provides long-acting, sustained antibiotic activity, effectively treating syphilis, rheumatic fever, and streptococcal infections. Benefits include reliable, prolonged eradication of bacteria with a single injection.
Benzathine Penicillin Intramuscular Injection is available in Intramuscular Injection
and strengths such as 600,000 units / mL; 1.2 million units / mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Benzathine Penicillin Intramuscular Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Benzathine Penicillin Intramuscular Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Benzathine penicillin IM injection is approved in the US and EU for treating syphilis, rheumatic fever, and streptococcal infections. In the US, brands like Bicillin L-A are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards, with strict guidelines due to antibiotic resistance. In the EU, approval depends on national regulations, with dossiers required to demonstrate quality and safety. Both regions enforce stringent prescribing, storage, and usage regulations. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access, ensuring adherence to European and US standards for safe, effective antibiotic therapy while navigating complex regulatory landscapes seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing